黑料网

1/25/2019 Andrew Learner (Strahl/Kuhlman labs) 鈥淓lucidating Dynamics of Histone Post-Translational Modifications Using Optogenetics鈥� Dr. Learner accepted a Fellowship in Innovation and Translation in the Eshelman Institute for Innovation at the 黑料网 Eshelman School of Pharmacy that begins in February 2020.

3/8/2019 Jacob Matson (Cook lab) 鈥淩egulation of MCM Helicase Loading During Early Differentiation and Cell Cycle Re-entry鈥� Dr. Matson accepted a postdoctoral fellow in Dr. Lee Zou’s lab at Massachusetts General Hospital/Harvard Medical School.

3/21/2019 Alex Chung (Parise lab, Pharmacology) 鈥淐IB1: A Promosing Target in Triple-Negative Breast Cancer鈥� Dr. Chung accepted a position as a Project Specialist at Syneos Health in Morrisville and will work on clinical operation and strategy.

03/29/2019 Sam Kistler (Campbell lab, Pharmacy 鈥� CBMC) 鈥淩as Acetylation Directs Effector Specificity鈥� Dr. Kistler accepted a position at Merck.

06/21/2019 Astor Ankney (Chen lab) 鈥淪ecretotranscriptomics: A Novel Approach to the Discovery of Liquid Biopsy Biomarkers for Breast Cancer Prognosis鈥� Dr. Ankney has accepted a position at

08/12/2019 Hyunna 鈥淭eresa鈥� Lee (Campbell lab) 鈥淩ole of Metavinculin in Actin Reorganization and Force Transmission鈥� Dr. Lee has accepted a position at National Institutes of Health (NIH).

08/14/2019 Megan Arrington (Campbell/Loeser labs, Chemistry) 鈥淭he molecular basis for Rac2 E62K immune deficiency鈥� Dr. Arrington is furthering her research at 黑料网 while seeking a position.

11/01/2019 Frank Teets (Hahn/Kuhlman labs, B&CB student) 鈥淔unction-Driven Approaches to the Design of Optogenetic Tools鈥� Dr. Teets has accepted a postdoctoral fellowship under Dr. Chris Bahl at the Institute for Protein Innovation at Harvard Medical School.